Stock Report: Bio-Rad Laboratories Inc. Cl A (BIO) Report Updated: Jun 17, 2013 | Print This Page
Report Features:
Stock Analysis
Rating: Monthly View
| A | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B | ||||||||||||
| C | ||||||||||||
| D | ||||||||||||
| F | ||||||||||||
Rating: Weekly View
| This Week: | D |
|---|---|
| Last Week: | C |
| Two Weeks Ago: | C |

Company Profile
Bio-Rad Laboratories, Inc. engages in the manufacture and distribution of life science research and clinical diagnostic products worldwide. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. This segment serves various customers, including universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for the healthcare market. This segment sells its products to reference laboratories, hospital laboratories, screening facilities, physicians’ office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Recent News: Bio-Rad Laboratories Inc. Cl A
My Portfolios (View All)
Save your portfolio—or a few for that matter—and check up on your stocks 24/7! Log in here.
Louis Navellier's Portfolios
- Blue Chip GrowthTop blue chips
- Emerging GrowthTop small-caps
- Ultimate GrowthFastest-moving
- Platinum GrowthElite Model Portfolio



